Civic Intelligence

Frontiers in Bioscience Inc.

990 • Fiscal year 2017 • EIN 59-3432665

Jan 01, 2017 to Dec 31, 2017 • Filed on Dec 23, 2018

Organization ProfileWWW.BIOSCIENCE.ORG
20 Sunset CoveNewport Coast, CA 92657

(949) 715-8286

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

14th percentile

0.00x

Higher debt load relative to assets than 14% of similar nonprofits.

2017 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2017

Liabilities / Revenue

21st percentile

0.04x

Higher debt load relative to revenue than 21% of similar nonprofits.

2017 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2017

Net Margin

87th percentile

36%

Higher net margin than 87% of similar nonprofits.

2017 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2017

Top Officer Pay

34th percentile

$88,000

Higher top officer pay than 34% of similar nonprofits.

Top officer pay equals 9.9% of source-year revenue.

2017 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2017

Asset Growth

46th percentile

2.9%

Faster asset growth than 46% of similar nonprofits.

2017 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2016 to 2017

Revenue Growth

80th percentile

29%

Faster revenue growth than 80% of similar nonprofits.

2017 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2016 to 2017

Balance Sheet
Liabilities / Assets14th percentile

Assets

Up

$7,939,484

Up $220,023 (+2.9%) from 2016

Net Assets

Up

$7,901,146

Up $321,484 (+4.2%) from 2016

Liabilities

Down

$38,338

Down $101,461 (-73%) from 2016

Revenue And Expenses
Liabilities / Revenue21st percentileNet Margin87th percentile

Revenue

Up

$884,845

Up $197,985 (+29%) from 2016

Expenses

Down

$563,361

Down $99,127 (-15%) from 2016

Net Income

Up

$321,484

Up $297,112 (+1219%) from 2016

Historical Trend

Balance Sheet Trend

Asset Growth46th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$10M$5.0M$0Assets 2011: $6,072,390Liabilities 2011: $145,555Net Assets 2011: $5,926,8352011Assets 2012: $6,593,702Liabilities 2012: $161,267Net Assets 2012: $6,432,4352012Assets 2013: $7,019,430Liabilities 2013: $158,293Net Assets 2013: $6,861,1372013Assets 2014: $7,380,585Liabilities 2014: $279,146Net Assets 2014: $7,101,4392014Assets 2015: $7,717,237Liabilities 2015: $161,947Net Assets 2015: $7,555,2902015Assets 2016: $7,719,461Liabilities 2016: $139,799Net Assets 2016: $7,579,6622016Assets 2017: $7,939,484Liabilities 2017: $38,338Net Assets 2017: $7,901,1462017Assets 2018: $8,152,585Liabilities 2018: $31,140Net Assets 2018: $8,121,4452018Assets 2019: $8,329,196Liabilities 2019: $28,843Net Assets 2019: $8,300,3532019Assets 2020: $9,154,107Liabilities 2020: $192,253Net Assets 2020: $8,961,8542020Assets 2021: $9,263,668Liabilities 2021: $187,520Net Assets 2021: $9,076,1482021Assets 2022: $9,068,473Liabilities 2022: $175,870Net Assets 2022: $8,892,6032022Assets 2023: $9,132,862Liabilities 2023: $252,072Net Assets 2023: $8,880,7902023Assets 2024: $9,147,259Liabilities 2024: $244,048Net Assets 2024: $8,903,2112024Assets 2025: $8,977,418Liabilities 2025: $246,462Net Assets 2025: $8,730,9562025

Highlighted filing

2017

Assets$7,939,484
Liabilities$38,338
Net Assets$7,901,146
Open 2017 Filing

Operations Trend

Revenue Growth80th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2011: $303,3232011Expenses 2012: $566,8742012Revenue 2013: $1,020,368Expenses 2013: $591,666Net Income 2013: $428,7022013Revenue 2014: $929,379Expenses 2014: $583,280Net Income 2014: $346,0992014Revenue 2015: $959,466Expenses 2015: $568,606Net Income 2015: $390,8602015Revenue 2016: $686,860Expenses 2016: $662,488Net Income 2016: $24,3722016Revenue 2017: $884,845Expenses 2017: $563,361Net Income 2017: $321,4842017Revenue 2018: $687,687Expenses 2018: $467,385Net Income 2018: $220,3022018Revenue 2019: $665,550Expenses 2019: $464,587Net Income 2019: $200,9632019Revenue 2020: $1,172,136Expenses 2020: $303,230Net Income 2020: $868,9062020Revenue 2021: $287,321Expenses 2021: $239,359Net Income 2021: $47,9622021Revenue 2022: $130,196Expenses 2022: $272,103Net Income 2022: -$141,9072022Revenue 2023: $252,831Expenses 2023: $264,644Net Income 2023: -$11,8132023Revenue 2024: $159,183Expenses 2024: $334,551Net Income 2024: -$175,3682024Revenue 2025: $179,746Expenses 2025: $394,681Net Income 2025: -$214,9352025

Highlighted filing

2017

Revenue$884,845
Expenses$563,361
Net Income$321,484
Open 2017 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Signed
Dec 23, 2018
Return Version
2017v2.2
Gross Receipts
$1,228,048
Mission and Program Overview

Mission

Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.

Frontiers in bioscience is an organization dedicated to fostering science,research and teaching. Fbs has been involved in these activities since jan1 1996. Fbs has published over 4000 scholarly scientific articles inmedicine and biology from well known scientists.fbs also carries research in understanding cancer since 2007 and has beenworking on aging reversal since 2011.our research on cancer is geared towards understanding the reason forcancer growth and recurrence as well as understanding the cause ofdisturbed metabolism (warburg's effect) of cancer cells. Such an insight issignificant since it provides us with new avenues for treatment of canceror cancer cure. The treatment of cancer based, on our hypothesis, isfounded on new non-chemotherapeutic and non-radiotherpay approaches. Wealso examine the cause of senescence, as well as approaches for reversal ordeceleration of this process. Based on such a background, we will examinewhether senescence can be reversed or decelarated in ani

Balance Sheet Detail
LineBeginningEndChange
Assets
Land, Buildings, and Equipment, Net$4,588,513$4,269,765▼ $318,748
Cash and Non-Interest-Bearing Accounts$3,125,497$3,665,059▲ $539,562
Loans From Officers Directors$120,237$11,953▼ $108,284
Investments in Publicly Traded Securities$4,660$4,660→ $0
Other Notes and Loans Receivable, Net$792$0▼ $792
Savings and Temporary Cash Investments-$0-
Accounts Receivable-$0-
Pledges and Grants Receivable-$0-
Receivable From Disqualified Prsn-$0-
Receivables From Officers Etc-$0-
Investments Other Securities-$0-
Investments Program Related-$0-
Intangible Assets-$0-
Inventories for Sale or Use-$0-
Prepaid Expenses and Deferred Charges-$0-
Total Assets$7,719,462$7,939,484▲ $220,022
Other Assets Total-$0-
Liabilities
Other Liabilities$16,291$19,689▲ $3,398
Accounts Payable and Accrued Expenses$3,272$6,696▲ $3,424
Total Liabilities$139,800$38,338▼ $101,462
Net Assets / Fund Balance
Unrestricted Net Assets$7,579,662$7,901,146▲ $321,484
Total Net Assets Fund Balance$7,579,662$7,901,146▲ $321,484
Total Liabilities and Net Assets / Fund Balance$7,719,462$7,939,484▲ $220,022

Asset Categories

AssetBook ValueDepreciationBasis
Land$2,779,413-$2,779,413
Buildings$1,173,442$282,664$1,456,106
Leasehold Improvements$265,302$101,392$366,694
Equipment$41,705$305,578$347,283
Other Land Buildings$9,903$54,986$64,889
Compensation and Service Providers
Top Officer Pay34th percentile

Employees

NameTitleFull / Part TimeBaseTotal
Siamak Tabibzadeh MdCEO, ResearcherFT$88,000$88,000

Board Members and Trustees

NameTitle
Richard CushmanSecretary
John TabacekTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$665,443
Investment Income
$190,777
Other Revenue
$28,625
Change in Net Assets
$321,484
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$318,935
Other Expenses$244,426
Total Fundraising Expense$12,393
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$195,000--$195,000
Current Officers, Directors, Trustees, and Key Employees$70,400$8,800$8,800$88,000
Depreciation Depletion---$64,406
Payroll Taxes$19,915$2,489$2,489$24,893
Fees for Services Legal-$17,684-$17,684
All Other Expenses$13,982--$13,982
Fees for Services Accounting-$12,719-$12,719
Other Employee Benefits$8,834$1,104$1,104$11,042
Fees for Services Other$11,012--$11,012
Occupancy$10,451--$10,451
Other Expenses$9,265--$9,265
Insurance$6,191--$6,191
Information Technology$4,298--$4,298
Office Expenses$1,093--$1,093
Travel$615--$615
Total Functional Expenses$443,766$42,796$12,393$563,361
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
Siamak TabibzadehCEOSalaryNo$88,000
Siamak TabibzadehCEOAccrued SalaryNo$18,000

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$120,237$11,953▼ $108,284
Receivables from Disqualified Persons-$0-
Receivables from Officers, Directors, Trustees, and Key Employees-$0-
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Tenant Deposit$16,890
Advanced Rent$2,795
Rounding$4
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
No
Business relationship with family members
No
Business relationship with organization members
Yes
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Line 11B: Form 990 Review Process

“Organization's process to review form 990 the form 990 is reviewed with the tax preparer as to accuracy and completeness.”

Form 990, Part VI, Line 12C: Explanation of Monitoring and Enforcement of Conflicts

“Conflict of interest policy - the board of directors reviews self-dealingtransactions regularly.”

Form 990, Part VI, Line 19: Other Organization Documents Publicly Available

“AVAILABLE UPON REQUEST.”

Filing and Contact Details

Filer

Filer Name
Frontiers in Bioscience
EIN
59-3432665
Phone
9497158286
Address
20 SUNSET COVE, NEWPORT COAST, CA 92657

Signing Officer

Name
Siamak Tabibzadeh Md
Title
CEO
Phone
9497158286
Signed
2018-12-23
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Siamak Tabibzadeh Md
Formed
1995
Legal Domicile
Fl
Voting Board Members
3
Independent Board Members
2
Employees
5

Preparer

Firm
Subhash Tax and Financial Services
Address
2914 RISING STAR DR, DIAMOND BAR, CA 91765-3425
Preparer
Parag Karia
Phone
9095984001
Raw XML AppendixShowing 400 of 445 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt03272
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt06696
IRS990/AccountsReceivableGrp/EOYAmt00
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE,RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES INMEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS.FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEENWORKING ON AGING REVERSAL SINCE 2011.OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FORCANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OFDISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT ISSIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCEROR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, ISFOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WEALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL ORDECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINEWHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANI
IRS990/AdvertisingGrp/TotalAmt00
IRS990/AllAffiliatesIncludedInd0false
IRS990/AllOtherExpensesGrp/ProgramServicesAmt013982
IRS990/AllOtherExpensesGrp/TotalAmt013982
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BackupWthldComplianceInd0false
IRS990/BenefitsToMembersGrp/TotalAmt00
IRS990/BooksInCareOfDetail/PersonNm0SIAMAK TABIBZADEH MD
IRS990/BooksInCareOfDetail/PhoneNum09497158286
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt020 SUNSET COVE
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEWPORT COAST
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd092657
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOfficerEntInd0true
IRS990/BusinessRlnWithOrgMemInd0true
IRS990/CashNonInterestBearingGrp/BOYAmt03125497
IRS990/CashNonInterestBearingGrp/EOYAmt03665059
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt08800
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt08800
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt070400
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt088000
IRS990/CompDisqualPersonsGrp/TotalAmt00
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/TotalAmt00
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt0190777
IRS990/CYOtherExpensesAmt0244426
IRS990/CYOtherRevenueAmt028625
IRS990/CYProgramServiceRevenueAmt0665443
IRS990/CYRevenuesLessExpensesAmt0321484
IRS990/CYSalariesCompEmpBnftPaidAmt0318935
IRS990/CYTotalExpensesAmt0563361
IRS990/CYTotalFundraisingExpenseAmt012393
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0884845
IRS990/DAFExcessBusinessHoldingsInd0false
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/TotalAmt064406
IRS990/Desc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE,RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES INMEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCHIN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSALSINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THEREASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSEOF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH ANINSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENTOF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS,IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL ORDECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINEWHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORETHEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILLHELP HUMANITY IN A GRAND SCALE.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DistributionToDonorInd0false
IRS990/DocumentRetentionPolicyInd0true
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt05
IRS990/EmploymentTaxReturnsFiledInd0true
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/EscrowAccountInd0false
IRS990/ExpenseAmt0443766
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt012719
IRS990/FeesForServicesAccountingGrp/TotalAmt012719
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt017684
IRS990/FeesForServicesLegalGrp/TotalAmt017684
IRS990/FeesForServicesLobbyingGrp/TotalAmt00
IRS990/FeesForServicesManagementGrp/TotalAmt00
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt011012
IRS990/FeesForServicesOtherGrp/TotalAmt011012
IRS990/FeesForServicesProfFundraising/TotalAmt00
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt00
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignGrantsGrp/TotalAmt00
IRS990/ForeignOfficeInd0false
IRS990/Form1098CFiledInd0false
IRS990/Form8282FiledCnt00
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form8899Filedind0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt00.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt10.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt20.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt060.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt22.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/PersonNm0SIAMAK TABIBZADEH MD
IRS990/Form990PartVIISectionAGrp/PersonNm1RICHARD CUSHMAN
IRS990/Form990PartVIISectionAGrp/PersonNm2JOHN TABACEK
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt088000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO, RESEARCHER
IRS990/Form990PartVIISectionAGrp/TitleTxt1Secretary
IRS990/Form990PartVIISectionAGrp/TitleTxt2Treasurer
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/Form990TFiledInd0true
IRS990/FormationYr01995
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GainOrLossGrp/OtherAmt0178432
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt03
IRS990/GrantsToDomesticIndividualsGrp/TotalAmt00
IRS990/GrantsToDomesticOrgsGrp/TotalAmt00
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossAmountSalesAssetsGrp/OtherAmt0450000
IRS990/GrossReceiptsAmt01228048
IRS990/GrossRentsGrp/RealAmt0100260
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IncmFromInvestBondProceedsGrp/TotalRevenueColumnAmt00
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt02
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ProgramServicesAmt04298
IRS990/InformationTechnologyGrp/TotalAmt04298
IRS990/InsuranceGrp/ProgramServicesAmt06191
IRS990/InsuranceGrp/TotalAmt06191
IRS990/IntangibleAssetsGrp/EOYAmt00
IRS990/InterestGrp/TotalAmt00
IRS990/InventoriesForSaleOrUseGrp/EOYAmt00
IRS990/InvestmentIncomeGrp/ExclusionAmt012345
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt012345
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsOtherSecuritiesGrp/EOYAmt00
IRS990/InvestmentsProgramRelatedGrp/EOYAmt00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt04660
IRS990/InvestmentsPubTradedSecGrp/EOYAmt04660
IRS990/InvestTaxExemptBondsInd0false
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0744620
IRS990/LandBldgEquipBasisNetGrp/BOYAmt04588513
IRS990/LandBldgEquipBasisNetGrp/EOYAmt04269765
IRS990/LandBldgEquipCostOrOtherBssAmt05014385
IRS990/LegalDomicileStateCd0FL
IRS990/LessCostOthBasisSalesExpnssGrp/OtherAmt0271568
IRS990/LessRentalExpensesGrp/RealAmt071635
IRS990/LicensedMoreThanOneStateInd0false
IRS990/LoanOutstandingInd0true
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt0120237
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt011953
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE,RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES INMEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS.FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEENWORKING ON AGING REVERSAL SINCE 2011.OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FORCANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OFDISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT ISSIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCEROR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, ISFOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WEALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL ORDECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINEWHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANI
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt07579662
IRS990/NetAssetsOrFundBalancesEOYAmt07901146
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0178432
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0178432
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeFromGamingGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt00
IRS990/NetRentalIncomeOrLossGrp/TotalRevenueColumnAmt028625
IRS990/NetRentalIncomeOrLossGrp/UnrelatedBusinessRevenueAmt028625
IRS990/NetUnrelatedBusTxblIncmAmt027625
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/ProgramServicesAmt010451
IRS990/OccupancyGrp/TotalAmt010451
IRS990/OfficeExpensesGrp/ProgramServicesAmt01093
IRS990/OfficeExpensesGrp/TotalAmt01093
IRS990/OfficerMailingAddressInd0false
IRS990/OnBehalfOfIssuerInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OrgFiledInLieuOfForm1041Ind0false
IRS990/OtherAssetsTotalGrp/EOYAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt01104
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt01104
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt08834
IRS990/OtherEmployeeBenefitsGrp/TotalAmt011042
IRS990/OtherExpensesGrp/Desc0BASIC RESEARCH LAB SUPPLIES
IRS990/OtherExpensesGrp/Desc1PROPERTY TAX
IRS990/OtherExpensesGrp/Desc2APP RES, LIFE EXTN, FOOD, SKIN
IRS990/OtherExpensesGrp/Desc3BANK AND CREDIT CARD FEES
IRS990/OtherExpensesGrp/ProgramServicesAmt038544
IRS990/OtherExpensesGrp/ProgramServicesAmt138509
IRS990/OtherExpensesGrp/ProgramServicesAmt215657
IRS990/OtherExpensesGrp/ProgramServicesAmt39265
IRS990/OtherExpensesGrp/TotalAmt038544
IRS990/OtherExpensesGrp/TotalAmt138509
IRS990/OtherExpensesGrp/TotalAmt215657
IRS990/OtherExpensesGrp/TotalAmt39265
IRS990/OtherLiabilitiesGrp/BOYAmt016291
IRS990/OtherLiabilitiesGrp/EOYAmt019689
IRS990/OtherRevenueTotalAmt00
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0195000
IRS990/OtherSalariesAndWagesGrp/TotalAmt0195000
IRS990/OthNotesLoansReceivableNetGrp/BOYAmt0792
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt00
IRS990/PartialLiquidationInd0false
IRS990/PaymentsToAffiliatesGrp/TotalAmt00
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt02489
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt02489
IRS990/PayrollTaxesGrp/ProgramServicesAmt019915
IRS990/PayrollTaxesGrp/TotalAmt024893
IRS990/PensionPlanContributionsGrp/TotalAmt00
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt00
IRS990/PrincipalOfficerNm0SIAMAK TABIBZADEH MD
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0PROGRAM SERVICE REVENUE
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0665443
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0665443
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt010651
IRS990/PymtTravelEntrtnmntPubOfclGrp/TotalAmt00
IRS990/PYOtherExpensesAmt0338193
IRS990/PYOtherRevenueAmt019406
IRS990/PYProgramServiceRevenueAmt0656803
IRS990/PYRevenuesLessExpensesAmt024372
IRS990/PYSalariesCompEmpBnftPaidAmt0324295
IRS990/PYTotalExpensesAmt0662488
IRS990/PYTotalRevenueAmt0686860
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvblFromDisqualifiedPrsnGrp/EOYAmt00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReceivablesFromOfficersEtcGrp/EOYAmt00
IRS990/ReconcilationRevenueExpnssAmt0321484
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/RentalIncomeOrLossGrp/RealAmt028625
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt0665443
IRS990/RoyaltiesGrp/TotalAmt00
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt00
IRS990/SavingsAndTempCashInvstGrp/EOYAmt00
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt00
IRS990ScheduleA/GovtFurnSrvcFcltsVl509Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt012345
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt010651
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt0883
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt05914
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt07546
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt037339
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt0692937
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0656803
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt0902183
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt0923465
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt01012822
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt04188210
IRS990ScheduleA/GrossReceiptsNonUnrltBusGrp/TotalAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt012345
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt010651
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt0883
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt05914
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt07546
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt037339
IRS990ScheduleA/InvestmentIncomeCYPct00.00880
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt00
IRS990ScheduleA/OtherIncome509Grp/TotalAmt00
IRS990ScheduleA/Post1975UBTIGrp/TotalAmt00
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99120
IRS990ScheduleA/PublicSupportTotal509Amt04188210
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft509Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0692937
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0656803
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt0902183
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0923465
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt01012822
IRS990ScheduleA/Total509Grp/TotalAmt04188210
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0705282
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0667454
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt0903066
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0929379
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt01020368
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt04225549
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/BuildingsGrp/BookValueAmt01173442
IRS990ScheduleD/BuildingsGrp/DepreciationAmt0282664
IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt01456106
IRS990ScheduleD/EquipmentGrp/BookValueAmt041705
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0305578
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0347283
IRS990ScheduleD/LandGrp/BookValueAmt02779413
IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt02779413
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt0265302
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0101392
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt0366694
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt09903
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt054986
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt064889
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt02795
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt14
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt216890
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0ADVANCED RENT
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1Rounding
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc2TENANT DEPOSIT
IRS990ScheduleD/TotalBookValueLandBuildingsAmt04269765
IRS990ScheduleD/TotalLiabilityAmt019689
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/PersonNm0SIAMAK TABIBZADEH
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/PersonNm1SIAMAK TABIBZADEH
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt0CEO
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt1CEO
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd1false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionAmt088000
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionAmt118000
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc0SALARY
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc1ACCRUED SALARY
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt011953
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt0154000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0SIAMAK TABIBZADEH NOTE
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0CEO
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0true
IRS990ScheduleL/TotalBalanceDueAmt011953
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0ORGANIZATION'S PROCESS TO REVIEW FORM 990 THE FORM 990 IS REVIEWED WITH THE TAX PREPARER AS TO ACCURACY AND COMPLETENESS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1CONFLICT OF INTEREST POLICY - THE BOARD OF DIRECTORS REVIEWS SELF-DEALINGTRANSACTIONS REGULARLY.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2AVAILABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990, Part VI, Line 11b: Form 990 Review Process
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990, Part VI, Line 19: Other Organization Documents Publicly Available
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxableDistributionsInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt07719462
IRS990/TotalAssetsEOYAmt07939484
IRS990/TotalAssetsGrp/BOYAmt07719462
IRS990/TotalAssetsGrp/EOYAmt07939484
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt00
IRS990/TotalEmployeeCnt05
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt012393
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt042796
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0443766
IRS990/TotalFunctionalExpensesGrp/TotalAmt0563361
IRS990/TotalGrossUBIAmt028625
IRS990/TotalLiabilitiesBOYAmt0139800
IRS990/TotalLiabilitiesEOYAmt038338
IRS990/TotalLiabilitiesGrp/BOYAmt0139800
IRS990/TotalLiabilitiesGrp/EOYAmt038338
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt07579662
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt07901146
IRS990/TotalProgramServiceExpensesAmt0443766
IRS990/TotalProgramServiceRevenueAmt0665443
IRS990/TotalReportableCompFromOrgAmt088000
IRS990/TotalRevenueGrp/ExclusionAmt0190777
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0665443
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0884845
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt028625

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2017 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$7,939,484
Liabilities
$38,338
Net assets
$7,901,146
Revenue
$884,845
Expenses
$563,361
Net income
$321,484
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$8.98$0.25$8.73$0.18$0.39$0.21
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.24$8.90$0.16$0.33$0.18
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.13$0.25$8.88$0.25$0.26$0.01
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.07$0.18$8.89$0.13$0.27$0.14
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.26$0.19$9.08$0.29$0.24$0.05
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.19$8.96$1.17$0.30$0.87
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.33$0.03$8.30$0.67$0.46$0.20
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.15$0.03$8.12$0.69$0.47$0.22
2017Detailed filing. Detailed filing data is available for this year.$7.94$0.04$7.90$0.88$0.56$0.32
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.72$0.14$7.58$0.69$0.66$0.02
2015Detailed filing. Detailed filing data is available for this year.$7.72$0.16$7.56$0.96$0.57$0.39
2014Detailed filing. Detailed filing data is available for this year.$7.38$0.28$7.10$0.93$0.58$0.35
2013XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.02$0.16$6.86$1.02$0.59$0.43
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.59$0.16$6.43$0.57
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.07$0.15$5.93$0.30